- Home
- SHIP vs NTHI Comparison
SHIP vs NTHI Comparison
Compare SHIP & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHIP
- NTHI
- Stock Information
- Founded
- SHIP 2008
- NTHI 2008
- Country
- SHIP Greece
- NTHI United States
- Employees
- SHIP N/A
- NTHI N/A
- Industry
- SHIP Marine Transportation
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- SHIP Consumer Discretionary
- NTHI Health Care
- Exchange
- SHIP Nasdaq
- NTHI Nasdaq
- Market Cap
- SHIP 131.9M
- NTHI 142.5M
- IPO Year
- SHIP 2007
- NTHI N/A
- Fundamental
- Price
- SHIP $6.48
- NTHI $6.80
- Analyst Decision
- SHIP Strong Buy
- NTHI
- Analyst Count
- SHIP 1
- NTHI 0
- Target Price
- SHIP $11.00
- NTHI N/A
- AVG Volume (30 Days)
- SHIP 109.1K
- NTHI 48.4K
- Earning Date
- SHIP 08-05-2025
- NTHI 01-01-0001
- Dividend Yield
- SHIP 11.75%
- NTHI N/A
- EPS Growth
- SHIP 48.17
- NTHI N/A
- EPS
- SHIP 1.26
- NTHI N/A
- Revenue
- SHIP $153,372,000.00
- NTHI $79,990.00
- Revenue This Year
- SHIP N/A
- NTHI N/A
- Revenue Next Year
- SHIP $21.78
- NTHI N/A
- P/E Ratio
- SHIP $5.12
- NTHI N/A
- Revenue Growth
- SHIP 17.53
- NTHI 13.52
- 52 Week Low
- SHIP $4.78
- NTHI $3.20
- 52 Week High
- SHIP $12.65
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- SHIP 50.95
- NTHI N/A
- Support Level
- SHIP $6.11
- NTHI N/A
- Resistance Level
- SHIP $6.74
- NTHI N/A
- Average True Range (ATR)
- SHIP 0.22
- NTHI 0.00
- MACD
- SHIP -0.05
- NTHI 0.00
- Stochastic Oscillator
- SHIP 40.00
- NTHI 0.00
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Fellowship, Championship, Partnership, Knightship, Lordship, Gloriuship, Leadership, Geniuship, Premiership, and Squireship, among others.
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").